<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2018-07-04" updated="2019-12-02">
  <drugbank-id primary="true">DB14233</drugbank-id>
  <name>Egg phospholipids</name>
  <description>Egg phospholipids are primarily a mixture of naturally occurring phospholipids which are isolated from the egg yolk. Egg phospholipids are available as an  intravenous fat emulsion indicated as a source of calories for patients requiring parenteral nutrition.</description>
  <cas-number>93685-90-6</cas-number>
  <unii>1Z74184RGV</unii>
  <groups>
    <group>approved</group>
    <group>experimental</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>For use as a source of calories for patients requiring parenteral nutrition.</indication>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Egg lecithin</synonym>
    <synonym language="english" coder="">Egg lecithin component of endolipide</synonym>
    <synonym language="english" coder="">Egg oil lecithin</synonym>
    <synonym language="english" coder="">Egg oil phospholipids</synonym>
    <synonym language="english" coder="">Egg phosphatides</synonym>
    <synonym language="english" coder="">Egg phospholipid</synonym>
    <synonym language="english" coder="">Egg phospholipids</synonym>
    <synonym language="english" coder="">Egg yolk lecithin</synonym>
    <synonym language="english" coder="">Egg yolk lecithins</synonym>
    <synonym language="english" coder="">Egg yolk phosphatides</synonym>
    <synonym language="english" coder="">Egg yolk phospholipids</synonym>
    <synonym language="english" coder="">Endolipide component egg lecithin</synonym>
    <synonym language="english" coder="">Lecithins, egg yolk</synonym>
    <synonym language="english" coder="">Phospholipids egg</synonym>
  </synonyms>
  <products>
    <product>
      <name>10% Travamulsion Liq IV</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02016028</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>20% Travamulsion Liq IV</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02016036</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liposyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9786</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-08-27</started-marketing-on>
      <ended-marketing-on>2011-02-01</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018997</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9789</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-08-27</started-marketing-on>
      <ended-marketing-on>2011-02-01</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018991</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn II 10%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00720976</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2014-08-01</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liposyn II 20%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00720968</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2014-08-01</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liposyn II Inj 10%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00818712</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-01-01</started-marketing-on>
      <ended-marketing-on>2014-08-01</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liposyn III</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9790</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-09-24</started-marketing-on>
      <ended-marketing-on>2011-07-01</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018969</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn III</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-9791</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-09-25</started-marketing-on>
      <ended-marketing-on>2011-07-01</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018970</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn III</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-6892</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-01</started-marketing-on>
      <ended-marketing-on>2011-06-01</ended-marketing-on>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020181</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liposyn III 10%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366800</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liposyn III 20%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366819</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>OB Complete Gold</name>
      <labeller>Vertical Pharmaceuticals, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68025-068</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-01-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Puralor</name>
      <labeller>Centurion Labs</labeller>
      <ndc-id/>
      <ndc-product-code>23359-700</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-01-01</started-marketing-on>
      <ended-marketing-on>2017-09-20</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Liposyn III</name>
      <ingredients>Egg phospholipids + Glycerin + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn II</name>
      <ingredients>Egg phospholipids + Safflower oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn II</name>
      <ingredients>Egg phospholipids + Safflower oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn III</name>
      <ingredients>Egg phospholipids + Glycerin + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn III</name>
      <ingredients>Egg phospholipids + Glycerin + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Puralor</name>
      <ingredients>1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine + 1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine + Acetylcysteine amide + Ascorbic acid + Cholecalciferol + Citric acid + Cobamamide + Egg phospholipids + Folic acid + Gastric intrinsic factor + L-threonic acid + Leucovorin + Levomefolic acid + Magnesium glycinate + Niacin + Pantethine + Papain + Riboflavin + Sodium citrate + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>OB Complete Gold</name>
      <ingredients>1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine + 1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine + 5-methyltetrahydrofolic acid + Calcium carbonate + Cholecalciferol + Cyanocobalamin + Egg phospholipids + Folic acid + Iron + Magnesium ascorbate + Potassium Iodide + Pyridoxine + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>10% Travamulsion Liq IV</name>
      <ingredients>Egg phospholipids + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>20% Travamulsion Liq IV</name>
      <ingredients>Egg phospholipids + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn II Inj 10%</name>
      <ingredients>Egg phospholipids + Safflower oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn II 20%</name>
      <ingredients>Egg phospholipids + Safflower oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn II 10%</name>
      <ingredients>Egg phospholipids + Safflower oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn III 10%</name>
      <ingredients>Egg phospholipids + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Liposyn III 20%</name>
      <ingredients>Egg phospholipids + Soybean oil</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, chewable</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents>
    <patent>
      <number>9717852</number>
      <country>United States</country>
      <approved>2017-08-01</approved>
      <expires>2033-04-08</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>228</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>